Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
October 9, 2006
- SELF-MEDICATION NEWS IN BRIEF
October 2, 2006
- R&D NEWS IN BRIEF
October 2, 2006
- More Companies Adopting New Method for Training MRs
October 2, 2006
- NEW PRODUCTS
October 2, 2006
- MREAC to Introduce New Seminar for MR Trainers
October 2, 2006
- Agilent Technology Launches New Compact LC/MS System, Highest Performance Q-TOF
October 2, 2006
- Daiichi Sankyo Holds Dialogue with Employees on Downsizing Plan
October 2, 2006
- Medtronic: Micro-Driver Stent System
October 2, 2006
- BUSINESS NEWS IN BRIEF
October 2, 2006
- MEDICAL DEVICE NEWS IN BRIEF
October 2, 2006
- SEMINAR Users' Complaints Are Gold Mines: Dr Tsuji of J&T Institute
October 2, 2006
- General Assembly of Med. Association-Operated Med. Facilities
October 2, 2006
- TOPICS GSK Opens Website on Blepharospasms,Hemifacial Spasms, Spasmodic Torticollis
October 2, 2006
- Med. Institutions Claiming Nicotine Dependence Management Fee Show Large Increase
October 2, 2006
- 200 Applications Received to Align Indications with Original Products
October 2, 2006
- Reducing Average Length of Hospital Stay Essential: Vice Minister
October 2, 2006
- Taiyo Pharm. Completes Seamless Production Line for Prefilled Syringes
October 2, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 2, 2006
- Wholesalers Must Offer Well-Grounded Prices: Korosho Hearing
October 2, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…